NCT03073200 Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT03066609 Study of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Status COMPLETED Phase PHASE3
NCT03065556 A Comparison of 188-0551 Solution Versus Vehicle Solution in Subjects With Plaque Psoriasis (Study 203) Status COMPLETED Phase PHASE2
NCT03055494 Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients Status COMPLETED Phase PHASE4
NCT03020199 Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE4
NCT03018509 Study to Evaluate Safety,Tolerability,Pharmacodynamics & Pharmacokinetics of JTE-451 in Active Plaque Psoriasis Subjects Status COMPLETED Phase PHASE1
NCT03005964 Safety and Efficacy Study Comparing AM001 Cream, 7.5% to Vehicle Cream in the Treatment of Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT03004339 Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test Status COMPLETED Phase PHASE1
NCT03000608 A Trial of a Botanical Drug (EISO) for Treatment of Mild-to-Moderate Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT03000309 Use of Apremilast in Patients Who Are Dissatisfied With Stable Maintenance Topical Therapy Status COMPLETED Phase PHASE4
NCT02993328 A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Plaque Psoriasis in Adults Status WITHDRAWN Phase PHASE2
NCT02932878 An Open Label, Safety Study to Assess the Potential for Adrenal Suppression Status COMPLETED Phase PHASE2
NCT02908347 Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients Status COMPLETED Phase PHASE2
NCT02899988 A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT02886702 A Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT02826603 Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT02752776 A Study to Evaluate Clear Skin Effect on Quality of Life in Patients With Plaque Psoriasis. Status COMPLETED Phase PHASE4
NCT02749799 Patient Satisfaction Following Twice Daily Dosing With DFD-01 in Subjects With Moderate Plaque Psoriasis Status COMPLETED Phase PHASE4